CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 135 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $4,608,000 | -28.5% | 900,000 | 0.0% | 0.18% | -21.0% |
Q2 2019 | $6,444,000 | -32.1% | 900,000 | +25.9% | 0.23% | -36.3% |
Q1 2019 | $9,495,000 | +96.6% | 715,000 | +16.5% | 0.37% | +60.5% |
Q4 2018 | $4,829,000 | -29.0% | 613,604 | 0.0% | 0.23% | -7.3% |
Q3 2018 | $6,799,000 | -12.7% | 613,604 | +5.8% | 0.25% | -18.0% |
Q2 2018 | $7,784,000 | +22.3% | 580,000 | +18.4% | 0.30% | +10.3% |
Q1 2018 | $6,365,000 | +53.7% | 490,000 | +8.9% | 0.27% | +44.7% |
Q4 2017 | $4,140,000 | +14.1% | 450,000 | 0.0% | 0.19% | +12.6% |
Q3 2017 | $3,627,000 | +269.0% | 450,000 | +350.0% | 0.17% | +45.2% |
Q4 2014 | $983,000 | -52.1% | 100,000 | -66.7% | 0.12% | -63.7% |
Q3 2014 | $2,052,000 | – | 300,000 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |